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In this paper, we describe the fabrication of a new biodegradable porous scaffold composed of polycaprolactone (PCL) and magnesium (Mg)
micro-particles. The compressive modulus of PCL porous scaffold was increased to at least 150% by incorporating 29% Mg particles with the
porosity of 74% using Micro-CT analysis. Surprisingly, the compressive modulus of this scaffold was further increased to at least 236% when the
silane-coupled Mg particles were added. In terms of cell viability, the scaffold modiﬁed with Mg particles signiﬁcantly convinced the attachment
and growth of osteoblasts as compared with the pure PCL scaffold. In addition, the hybrid scaffold was able to attract the formation of apatite
layer over its surface after 7 days of immersion in normal culture medium, whereas it was not observed on the pure PCL scaffold. This in vitro
result indicated the enhanced bioactivity of the modiﬁed scaffold. Moreover, enhanced bone forming ability was also observed in the rat model
after 3 months of implantation. Though bony in-growth was found in all the implanted scaffolds. High volume of new bone formation could be
found in the Mg/PCL hybrid scaffolds when compared to the pure PCL scaffold. Both pure PCL and Mg/PCL hybrid scaffolds were degraded
after 3 months. However, no tissue inﬂammation was observed. In conclusion, these promising results suggested that the incorporation of Mg
micro-particles into PCL porous scaffold could signiﬁcantly enhance its mechanical and biological properties. This modiﬁed porous bio-scaffold
may potentially apply in the surgical management of large bone defect ﬁxation.
& 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
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Bone tissue engineering offers an alternative solution to the
traditional methods of bone replacement including allografts
and autografts [1]. Tissue grafting has been used since the
1660s [2]. Bone grafts are the second most common trans-
plantating tissue with more than 2.2 million bone grafting10.1016/j.pnsc.2014.08.013
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ss: wkkyeung@hku.hk (K.W.K. Yeung).procedures conducted worldwide annually [3,4]. Autografts
have been remained as the gold standard in bone transplanta-
tion for bridging bone deﬁciencies such as repairing large bone
defects [1,5,6]. Although they possess good osteoinductive and
osteoconductive properties, both autografts and allografts have
limitations in terms of the availability and donor site morbidity
during autologous bone graft harvesting procedures and the
risk of disease transmission with the use of allografts [6–8].
Therefore, the use of synthetic scaffold is the most common
technique and good approach to regenerate diseased or damaged
bone tissue. An ideal bone substitute should possess certain
properties including osteoconductivity, biodegradability as well asElsevier B.V. All rights reserved.
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such as calcium phosphate and calcium sulphate is the most
commonly used material for bone regeneration due to its
bioactive properties [11]. However, its brittleness and fast
resorption rate are concerned clinically [12,13]. Biodegradable
polymer is another type of potential bone graft substitutes.
Polycaprolactone (PCL) is one of the suitable candidate, since
it is a FDA approved biodegradable polymer with low degrada-
tion rate when compared with poly(lactic-co-glycolic acid)
(PLGA) and polylactic acid (PLA) [14]. However, the low
mechanical strength and intrinsic hydrophobic properties of this
bio-degradable polymer may limit its use in orthopaedics [2,15].
Hence, modiﬁcation is warranted in order to improve its
mechanical and biological properties. Magnesium is a potential
additive, as particular amount of magnesium ions may up-
regulate the osteogenic markers and promote new bone formation
in our previous studies [16]. Also, magnesium ion (Mg2þ ) is
essential to human metabolism in which it can affect many
cellular functions including the transportation of potassium and
calcium ions, the modulation of signal transduction, energy
metabolism and cell proliferation [17,18]. Furthermore, the
literatures reported that the majority of magnesium content was
found in the bone system [19,20]. Therefore, these ﬁndings
highlighted the signiﬁcance of magnesium to human body and
bone growth. In this study, our group has fabricated a polymeric–
metallic hybrid biodegradable porous scaffold made of PCL and
magnesium (Mg) micro-particles in order to facilitate bony in-
growth after implantation. This paper reports the mechanical,
in vitro and in vivo properties of the newly developed scaffold.2. Experimental
2.1. Materials
Commercial magnesium particles in micron size (i.e. 45 μm
and 150 μm) (International Laboratory, USA) and polycapro-
lactone (PCL) (Sigma-Aldich, USA) with the average mole-
cular weight of Mn 80,000 g/mol were used for the scaffold
fabrication. Silane coupling agent, 3-(trimethoxysilyl) propyl
methacrylate (TMSPM) (Sigma, USA) was used to coat on the
surface of Mg particles in order to enhance the bonding
between PCL and Mg. The treatment parameters and the
characterisation of the silane coating after treatment were
reported in our previous study [16]. Salt leaching technique
was used for the scaffold fabrication. In brief, 1 g of PCL was
dissolved in 10 ml organic solvent, dichloromethane (DCM).
After that, 10 ml cold 100% ethanol was added to the PCL
polymer solution in order to displace the organic solvent. 0.4 g
of Mg micro-particles with either 45 μm or 150 μm particle
size were then added to the mixture to form the polymer slurry
and 7 g of sodium chloride (NaCl) was added and mixed
thoroughly. The mixture was pour into a mould and wait
overnight until all the solvent evaporated. Finally, the sample
was immersed into sodium hydroxide (NaOH) solution to allow
the NaCl to leach out in order to obtain porous structure. Four
types of Mg/PCL scaffold were fabricated (i.e. 45 μm Mg/PCLand 150 μm Mg/PCL scaffolds with and without TMSPM silane
coupling agent treatment). The volume fractions of Mg particles
in the four resultant scaffolds are 20%. Scaffolds with
10 mm 10 mm 5 mm were prepared for both mechanical
test and in vitro studies, while scaffolds with 2 mm in diameter
and 6 mm in length were prepared for in vivo study.2.2. Characterisation
The surface morphology of the fabricated scaffolds was
examined by scanning electron microscopy (SEM, Hitachi
S-3400N) and the porosity of the scaffolds was analysed by
using micro-computed tomography (Micro-CT) analysis (SKY-
SCAN 1076, Skyscan Company). 3D model of the fabricated
scaffold was generated by CTVol (Skyscan Company).
2.3. Mechanical test
In order to characterise the effectiveness of the incorporation
of Mg particles and also the TMSPM silane coating, compres-
sion test was conducted on pure PCL scaffold, uncoupled and
silane-coupled Mg/PCL scaffolds. The compression test was
performed according to the ASTM D695-08 protocol and the
compressive moduli were evaluated after testing.
2.4. In vitro studies
2.4.1. Cell viability of the scaffolds
MTT assay was used to determine the cytotoxicity of the
uncoupled and silane-coupled Mg/PCL scaffolds to murine cells.
7 105 cells/cm2 mouse MC3T3-E1 pre-osteoblasts were cultured
in the DMEM culture medium supplemented with 10% (v/v) foetal
bovine serum (FBS, Biowest, France), antibiotics (100 U/ml of
penicillin and 100 μg/ml of streptomycin), and 2 mM L-glutamine.
The cells were seeded on a 96-well tissue culture plate and
incubated at 37 1C in an atmosphere of 5% CO2 and 95% air for 3
days. After that, 10 μl of 5 mg/ml MTT solution, which was
prepared by dissolving thiazolyl blue tetrazolium bromide powder
into the phosphate buffered saline (PBS, OXOID Limited,
England) was added to each well and further incubated for 1
day. 100 μl of 10% sodium dodecyl sulphate (SDS, Sigma, USA)
in 0.01 M hydrochloric acid was then added and incubated
overnight. Finally, the absorbance was recorded by using multi-
mode detector (Thermo Scientiﬁc MULTISKAN GO) at a
wavelength of 570 nm with a reference wavelength of 640 nm.
The cell viability was then determined from the absorbance.2.4.2. Cytocompatibility of the silane-coupled Mg/PCL scaffolds
The cytocompatibility of the scaffolds were studied by direct
culture using Enhanced Green Fluorescent Protein Osteoblasts
(eGFPOB) from GFP mice. The scaffolds were immersed into
DMEM culture medium for 7 days prior cell culture in order to
enhance the attachment of the cells. 7 105 cells/cm2GFPOB
were seeded on each sample in 96-well plate and the cells were
cultured in the same condition as in the MTT assay. After 3
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ﬂuorescent microscopy (Niko ECL IPSE 80i, Japan) equipped
with a Sony DKS-ST5 digital camera.2.5. Bioactivity test
To determine the bioactivity of the scaffolds with and
without the incorporation of Mg particles, all the scaffolds
were immersed into DMEM culture medium for 7 days.
After that, the scaffolds were viewed and examined under
scanning electron microscopy (SEM, Hitachi S-3400N) and
the surface composition was analysed by energy-dispersive X-
ray spectroscopy (EDX).Fig. 1. Intra-operative picture of scaffold implantation in the lateral epicondyle
of SD rat. Black arrow shows the insertion position of the scaffold.
Fig. 2. (a) Surface morphology of the pure PCL and Mg/PCL hybrid porous s
reconstruction model of the fabricated scaffold.2.6. In vivo study
2.6.1. Surgical procedure
After characterisation and in vitro studies, animal study was
performed to study the biocompatibility of the selected
scaffold. The anaesthetic, surgical and post-operative care
protocols were examined and fulﬁlled the requirements of
the University Ethics Committee of the University of Hongcaffolds examined by scanning electron microscopy and (b) Micro-CT 3D
Fig. 3. Compressive moduli of the pure PCL scaffold, Mg/PCL and silane-
coupled Mg/PCL porous scaffolds. The compressive moduli of both the
Mg/PCL and silane-coupled Mg/PCL scaffolds were found to be signiﬁcantly
higher (*po0.05) than the pure PCL scaffold. In addition, the compressive
moduli of the TMSPM silane-coupled 150 μm Mg/PCL porous scaffolds was
signiﬁcantly higher (♯po0.05) than the 150 μm Mg/PCL scaffold.
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2-Month old female Sprague–Dawley rats (SD rats) with the
average weight of 200–250 g from the Laboratory Animal Unit
of the University of Hong Kong were used in this study.
Each rat was implanted with pure PCL, or silane-coupledFig. 4. Cell viability of MC3T3-E1 pre-osteoblasts cultured on pure PCL, Mg/
PCL and TMSPM silane-coupled porous Mg/PCL scaffolds using MTT
assay. Cell viability was found signiﬁcantly higher in both Mg/PCL and
TMSPM silane-coupled porous scaffolds as compared to the pure PCL scaffold
(po0.05).
Fig. 5. Microscopic view of (a and d) pure PCL, (b and e) TMSPM-coupled 45 μm
PCL scaffold after cultured with GFP mouse osteoblasts for 3 days. The scaffolds
culturing. 7 105 cells/cm2 GFPOB were cultured on each scaffold in the 96-well
show the scaffolds with higher magniﬁcation (40 ).Mg/PCL scaffolds on either the left or right side of the lateral
epicondyle. For the surgical operation procedures, the rats
were anaesthetized with ketamine (67 mg/kg) and xylazine
(6 mg/kg) by intraperitoneal injection. After hair shaving and
decortication of the operation site, a hole with 2 mm in
diameter and 6 mm in depth was drilled by a hand driller.
After that, the pure PCL scaffold and silane-coupled scaffold
were implanted into the holes on either left or right femur
(Fig. 1) and the wound were then closed layer by layer with
proper wound dressing applied. After surgery, 1 mg/kg terra-
mycin (antibiotics) and 0.5 mg/kg ketoprofen (analgesic) were
injected into the operated rats through subcutaneous injection.
The rats were euthanized 3 months after surgery.2.6.2. Histological analysis
The bone samples with scaffolds were harvested after 3 months
and they were ﬁxed in 10% buffered formalin for 3 days followed
by a standard tissue processing procedure. In brief, a dehydrating
process was carried out from 70% to 100% ethanol. After that,
xylene was used as a transition medium between ethanol and
methyl-methacrylate. The samples were immersed in each of the
solutions mentioned above for 3 days. Finally, all the bone samples
were embedded in methyl-methacrylate (MMA, MERCK, Ger-
many). The embedded samples were cut into sections with 200 μm
think and then ground to a thickness of approximately 60 μm. The
polished samples were then stained with Giemsa (MERCK,
Germany) and the morphological analysis including bone growth
and integration with host tissue was examined using optical
microscopy.particle Mg/PCL scaffold, and (c and f) TMSPM-coupled 150 μm particle Mg/
were immersed into the DMEM culture medium for 7 days prior to the cell
plate. (a–c) show the scaffolds with lower magniﬁcation (20 ), whereas (d–f)
Fig. 6. Scanning electron microscopic pictures of (a) pure PCL and (b) TMSPM-coupled 45 μm particle Mg/PCL scaffold, and (c) TMSPM-coupled 150 μm
particle Mg/PCL scaffold after immersed in the DMEM culture medium for 7 days. Surface chemical compositions of PCL, silane-coupled Mg/PCL porous
scaffolds were examined by using energy-dispersive X-ray spectroscopy. An apatite layer composed of magnesium (Mg), calcium (Ca) and phosphate (P) was
found to be deposited on the TMSPM silane-coupled Mg/PCL porous scaffolds (c1 and c2) after immersion but not found on the pure PCL scaffold.
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3.1. Morphology and porosity of the scaffolds
The surface morphology of the pure PCL scaffold and Mg-
incorporated PCL scaffolds is shown in Fig. 2a. The pore size
of the scaffolds was in the range from 200 μm to 500 μm.
Fig. 2b shows the 3D model of the fabricated scaffold and the
porosity of the scaffolds was found to be approximately 74%
by Micro-CT analysis.
3.2. The compressive modulus of porous scaffolds
Fig. 3 shows the compressive moduli of the pure PCL,
silane-coupled and uncoupled Mg/PCL scaffolds. Thecompressive modulus of the pure PCL scaffold was found to
be 0.4 MPa, while the compressive moduli of the 45 μm and
150 μm Mg micro-particles incorporated scaffolds were 1 MPa
and 1.4 MPa, respectively. The compressive property of these
modiﬁed scaffolds were signiﬁcantly higher than the pure PCL
scaffold. The increased moduli suggested that the addition of
the Mg micro-particles was able to enhance the mechanical
properties of the PCL scaffolds. Additionally, the compressive
moduli were further increased when the Mg micro-particles
coupled with TMSPM coupling agent. The increase was
signiﬁcant in particular to the 150 μm incorporated Mg/PCL
scaffold. TMSPM is the silane coupling agent commonly used
in modifying the adhesion of inorganic particles to polymer
matrix [21]. Expectedly, the bonding between PCL and Mg
was enhanced after this treatment. Hence, the compressive
Fig. 7. Histological photographs of bony tissue around the pure PCL, TMSPM-coupled 45 μm particle Mg/PCL porous scaffold, and TMSPM-coupled 150 μm
particle Mg/PCL porous scaffold after 3 months of implantation: (a–c) the location of the scaffolds in yellow dotted line in 40 magniﬁcation and (d–f) the newly
formed bone and the presence of osteoblast-like cells (green arrows) within the scaffolds in 200 magniﬁcation.
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2.2 MPa, which was doubled as compared with the scaffold
without the additional treatment. The silane-coupled 45 μm Mg/
PCL scaffold was slightly higher than the uncoupled scaffold;
though the difference was found insigniﬁcant.
3.3. In vitro cytotoxicity and cytocompatibility of the scaffolds
Fig. 4 shows the cell viability of the pure PCL scaffold and
silane-coupled and uncoupled Mg/PCL scaffolds using MTT
assay. Signiﬁcantly higher cell viability was found on all the
Mg incorporated scaffolds as compared with the pure PCL
scaffold. This result suggested that the release of Mg ions upon
degradation was able to enhance the viability of pre-osteoblasts.
Previous studies proposed that the presence of magnesium was
able to enhance cell adhesion and also stimulated bone growth
and bone healing [22–24]. In addition, this in vitro result was
consistent to our previous studies, which speciﬁc amount of Mg
ions released was able to stimulate cellular activity [16]. The
presence of Mg micro-particles could improve the overall
cellular activity of PCL/Mg scaffold thereof. No signiﬁcant
difference of cell viability was found before and after silane
coupling agent treatment. This result hopefully suggested that
the silane coating on Mg micro-particles did not jeopardise the
cyto-compatibility of the hybrid scaffold, while the mechanical
property enhanced.
In addition to the cell viability test, the cytocompatibility of
all the scaffolds were also examined with the use of the eGFP
primary mouse osteoblasts as shown in Fig. 5. Due to the green
ﬂuorescent property of the osteoblasts, the green colour repre-
sented the living cells. The TMSPM silane-coupled Mg/PCL
scaffolds were fully covered by living osteoblasts as comparedwith the pure PCL scaffold, indicated that the addition of Mg
micro-particles was able to enhance cell attachment and growth.
3.4. Bioactivity of the scaffolds
Fig. 6 reveals the surface morphology and composition of
the pure PCL scaffold and Mg/PCL scaffolds after 7 days of
DMEM immersion. Apart from the detection of Mg element,
an apatite layer composed of calcium (Ca) and phosphate (P)
was also found on the Mg/PCL scaffolds. However, no apatite
layer was found on the pure PCL scaffold, suggested that the
Mg/PCL hybrid scaffolds were highly bioactive. Indeed, the
literatures mentioned that the apatite layer could provide
favourable environment for new bone formation [25,26].
Therefore, the osteoinductivity and osteoconductivity of PCL
scaffold could be enhanced after the incorporation of Mg
micro-particles [27].3.5. In vivo study
Fig. 7 displays the histological analysis of bony in-growth
and on-growth within and adjacent to the scaffolds implanted
for 3 months with the use of Giemsa staining. The purple
colour represented the site of new bone formation. The yellow
dotted-line circle showed in 40 magniﬁcation photographs
indicated the circumference of the scaffolds. After implanted
for 3 months, all the scaffolds already degraded and new bone
formation was observed within and adjacent to the scaffolds.
No sign of inﬂammation was observed in both pure PCL and
Mg/PCL scaffolds. When compared with the pure PCL
scaffold, high amount of newly formed bony tissue was
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observation demonstrated that the pores within the scaffolds
were interconnected such that bony tissue could grow into the
scaffolds. While referring to the histological slides with 200
magniﬁcation, osteoblast-like cells were found next to the
newly formed bone (green arrows) in the silane-coupled
Mg/PCL hybrid scaffolds. Unfortunately, the mentioned cells
did not appear in the pure PCL scaffold. More bone formation
found in the hybrid scaffold in vivo was induced by the
superior forming ability of apatite layer. All these observations
may attribute to the enhancement of scaffold bioactivity due to
the release of magnesium ions. Indeed, it was recently reported
that the presence of magnesium in the bone system is
beneﬁcial to bone growth and also play a key role in bone
remodelling and skeletal development [18,20]. Literatures have
been shown that the in situ release of magnesium ions is able
to stimulate local bone formation and also bone healing by
enhancing the osteoblast and osteoclast activities [16,22,23].
However, the amount of Mg ions released is critical for bone
formation [28,29]. Too much ions released would lead to bone
loss [30]. Hence, in addition to the improvement of mechanical
properties of scaffold, the amount of Mg micro-particles
incorporated into the scaffold should be carefully controlled
so as to avoid any adverse biological effect due to over release
of magnesium ions [30,31].
4. Conclusions
This study demonstrates that the incorporation of the
magnesium micro-particles to pure PCL scaffold is able to
improve its poor mechanical properties and inferior bioactivity.
The compressive modulus of PCL scaffold has been signiﬁ-
cantly increased when magnesium micro-particles added. Its
mechanical property can be further enhanced by silane-coupled
magnesium micro-particles. Furthermore, the Mg/PCL hybrid
porous scaffolds possess superior mechanical property, cyto-
compatibility and bioactivity as compared with the pure PCL
scaffold. All these promising results have shown that the
magnesium micro-particle modiﬁed porous scaffold is a poten-
tial bone substitute candidate for large bone defect ﬁxation.
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